Fayuvi is Ultragenyx's second approved gene therapy after Genglycos (pariglasgene brecaparvovec) for glycogen storage disease ...

Around 1,000 patients in England with a form of incurable breast cancer will be able to get access to AstraZeneca and Daiichi ...

Generating good-quality patient experience data (PED) is becoming increasingly important for medicine development, and ...

Gilead's twice-yearly injectable for pre-exposure prophylaxis (PrEP) of HIV, lenacapavir, will not be routinely funded by the ...

Frehemgo (denecimig, also known as Mim8) – which picked up its first world approval in Saudi Arabia a few days ago – has been ...

Chinese tech giant ByteDance – best known as the parent of social media app TikTok – has completed a $290 million financing ...

The Danish Group stated that the new corporate culture – dubbed 'The Novo Way' – centres around four Cs; namely, customer ...

Avalere Health was the most successful agency, winning three Golds, a Silver and the highly contested accolade of PMi Agency ...

Boardrooms, Advisory Boards, and governance teams saw plenty of activity in August, with companies across biotech, ...

Jiangsu Hengrui Pharma's oral thrombopoietin (TPO) receptor agonist hetrombopag has been approved in China to treat low ...

Curium's radioligand therapy Bexlutry has been approved in the US as a generic – or 'radioligand equivalent' (RLE) – of ...

Amgen's fast-growing cancer immunotherapy Imdelltra could move into the first-line setting in small cell lung cancer (SCLC), ...